ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3139

Breaking the Cycle: Analyzing Preventable Hospital Admissions Due to Gout

Pieusha Malhotra1, Nikky Keer2 and Robert Yood3, 1Internal Medicine, Department of Medicine, Division of Rheumatic Diseases and Musculoskeletal Medicine, Saint Vincent Hospital, Worcester, MA, 2Internal medicine, Department of Medicine, Division of Rheumatic Diseases and Musculoskeletal Medicine, Saint Vincent Hospital, Worcester, MA, 3Department of rheumatology and musculoskeletal medicine, Department of Medicine, Division of Rheumatic Diseases and Musculoskeletal Medicine, Saint Vincent Hospital, Worcester, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Access to care, gout, Health Care, prevention and quality improvement

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Quality Measures and Quality of Care II

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Despite available effective treatment options and published guidelines for gout management, many patients suffer from recurrent gout attacks. Increases in gout prevalence and continued suboptimal gout care result in an increase in hospitalizations and health care utilization. We analyzed admissions due to gout in a community teaching hospital in order to ascertain whether these hospitalizations were preventable and to identify deficits in care prior to admission.

Methods:

We identified adult patients hospitalized at our institution from 01/01/2011 to 12/31/2014 with a primary discharge diagnosis of gout. A preventable admission was defined as a final diagnosis of gout without any coexisting conditions on presentation warranting admission, determined by chart review. We reviewed demographic characteristics, diagnosis on admission, prior history of gout, risk factors for gout, gout medication use prior to hospitalization, serum uric acid levels on admission, date and time of admission including overnight and weekend admissions, history of outpatient follow-up for treatment of gout, use of arthrocentesis, and duration of inpatient stay.

Results:

Ninety one patients were discharged with a primary diagnosis of gout, 71 (78%) of whom met criteria for preventable admission. Diagnosis on admission included pain 27 (38%), pain and joint swelling 4 (5%), joint effusion 4 (5%), acute gouty arthritis 26 (36%), cellulitis 10 (14%), osteomyelitis 2 (3%), and one patient was admitted to rule out deep vein thrombosis. Twenty four patients underwent arthrocentesis, but only 5 of these procedures were done in the Emergency Department (ED) prior to admission. Fifty patients (70%) had a prior history of gout, although 35 (70%) of them had no documentation of any outpatient provider managing their gout. 12 (23%) were managed by primary care providers, 3 (5%) by a rheumatologist. Risk factors for gout included hypertension 63 (88%), chronic kidney disease 27 (38%), aspirin therapy 34 (47%), and diuretic therapy 46 (64%). 20 (28%) were receiving urate lowering therapy (ULT), and 8 (11%) chronic colchicine. Seventeen (85%) of the patients treated with allopurinol received no prophylactic therapy. Only 10 (14%) had serum uric acid levels at target of <6 mg/dL, 27 (59%) had a uric acid level between 8-10 mg/dL, and 15 (21%) above 10 mg/dL. Ten (14%) had no documentation of their uric acid level. Twenty (28%) of the admissions were during the weekend, and 33 (46%) were admitted between the hours of 5pm and 7am. Overall aggregate length of stay for the preventable admissions was 179 days (mean 2.59 days).

Conclusion: Our findings demonstrate that 78% of the hospitalizations with a primary discharge diagnosis of gout were preventable. Lapses in the outpatient management of gout were apparent, as most of the patients did not have ongoing outpatient gout management, and few received concomitant prophylactic therapy when treated with ULT or had serum uric acid levels at target. A significant number of patients were admitted via the ED at night and on weekends. Arthrocentesis appeared to be underutilized in the ED. Interventions to address gaps in outpatient and ED care for gout are needed to prevent unnecessary admissions and decrease hospitalization-related costs.


Disclosure: P. Malhotra, None; N. Keer, None; R. Yood, None.

To cite this abstract in AMA style:

Malhotra P, Keer N, Yood R. Breaking the Cycle: Analyzing Preventable Hospital Admissions Due to Gout [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/breaking-the-cycle-analyzing-preventable-hospital-admissions-due-to-gout/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/breaking-the-cycle-analyzing-preventable-hospital-admissions-due-to-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology